Longevity & AgingWhy Exercise Still Matters When You Take GLP-1 Weight Loss Drugs
GLP-1 receptor agonists like semaglutide and tirzepatide produce larger short-term weight loss than exercise alone, but they also cause some lean mass loss, and weight often returns after the drug is stopped. This narrative review of literature from 2015 to 2025 concludes that exercise, especially resistance training, preserves muscle, supports fitness and may help maintain weight loss. Lean mass makes up roughly 15–40% of weight lost on these drugs. Combining medication with exercise, adequate protein and behavioral support appears more promising than medication alone, though evidence on optimal protocols and long-term outcomes is limited. The authors propose a three-step activity plan and expect future obesity care to favor hybrid drug-plus-lifestyle models.
